DYNAVAX TECHNOLOGIES CORPDYNAVAX TECHNOLOGIES CORPDYNAVAX TECHNOLOGIES CORP

DYNAVAX TECHNOLOGIES CORP

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.35 B‬EUR
‪−5.79 M‬EUR
‪210.45 M‬EUR
‪130.25 M‬
Beta (1Y)
−0.06

About Dynavax Technologies Corporation

CEO
Ryan Spencer
Headquarters
Emeryville
Employees (FY)
408
Founded
1996
FIGI
BBG000DY8TX2
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DYF1 is 10.37 EUR — it hasn't changed in the past 24 hours. Watch DYNAVAX TECHNOLOGIES CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange DYNAVAX TECHNOLOGIES CORP stocks are traded under the ticker DYF1.
DYF1 stock has fallen by 1.24% compared to the previous week, the month change is a 6.03% fall, over the last year DYNAVAX TECHNOLOGIES CORP has showed a 11.18% decrease.
We've gathered analysts' opinions on DYNAVAX TECHNOLOGIES CORP future price: according to them, DYF1 price has a max estimate of 26.74 EUR and a min estimate of 18.44 EUR. Watch DYF1 chart and read a more detailed DYNAVAX TECHNOLOGIES CORP stock forecast: see what analysts think of DYNAVAX TECHNOLOGIES CORP and suggest that you do with its stocks.
DYF1 reached its all-time high on Nov 4, 2021 with the price of 18.69 EUR, and its all-time low was 2.74 EUR and was reached on Apr 9, 2020. View more price dynamics on DYF1 chart.
See other stocks reaching their highest and lowest prices.
DYF1 stock is 0.96% volatile and has beta coefficient of −0.06. Track DYNAVAX TECHNOLOGIES CORP stock price on the chart and check out the list of the most volatile stocks — is DYNAVAX TECHNOLOGIES CORP there?
Today DYNAVAX TECHNOLOGIES CORP has the market capitalization of ‪1.35 B‬, it has decreased by 1.83% over the last week.
Yes, you can track DYNAVAX TECHNOLOGIES CORP financials in yearly and quarterly reports right on TradingView.
DYNAVAX TECHNOLOGIES CORP is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
DYF1 earnings for the last quarter are −0.06 EUR per share, whereas the estimation was −0.02 EUR resulting in a −196.92% surprise. The estimated earnings for the next quarter are 0.06 EUR per share. See more details about DYNAVAX TECHNOLOGIES CORP earnings.
DYNAVAX TECHNOLOGIES CORP revenue for the last quarter amounts to ‪47.07 M‬ EUR, despite the estimated figure of ‪50.95 M‬ EUR. In the next quarter, revenue is expected to reach ‪71.51 M‬ EUR.
DYF1 net income for the last quarter is ‪−8.08 M‬ EUR, while the quarter before that showed ‪198.42 K‬ EUR of net income which accounts for ‪−4.17 K‬% change. Track more DYNAVAX TECHNOLOGIES CORP financial stats to get the full picture.
No, DYF1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 3, 2024, the company has 408.00 employees. See our rating of the largest employees — is DYNAVAX TECHNOLOGIES CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DYNAVAX TECHNOLOGIES CORP EBITDA is ‪−12.52 M‬ EUR, and current EBITDA margin is −11.53%. See more stats in DYNAVAX TECHNOLOGIES CORP financial statements.
Like other stocks, DYF1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DYNAVAX TECHNOLOGIES CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DYNAVAX TECHNOLOGIES CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DYNAVAX TECHNOLOGIES CORP stock shows the sell signal. See more of DYNAVAX TECHNOLOGIES CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.